et al.. et al. et al..
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

The tip of the iceberg: opportunistic screening for Chlamydia trachomatis in asymptomatic patients attending a young people’s health clinic reveals a high prevalence — a pilot study

Stephanie Jones A C , Sue Barker B , Eugene Athan A and Stephen Graves A

A Barwon Health, Geelong, Vic. 3220, Australia;

B Clockwork Young Peoples Health Service, 60 Little Malop Street, Geelong, Vic. 3220, Australia.

C Author for correspondence; email: stephljones@yahoo.com.

Sexual Health 1(2) 115-119 https://doi.org/10.1071/SH03007
Submitted: 22 September 2003  Accepted: 3 February 2004   Published: 24 June 2004

Abstract

Objectives: We implemented an opportunistic screening programme for Chlamydia trachomatis amongst patients presenting to a young peoples’ health service in the city of Geelong, Australia, to define the prevalence of infection and to identify specific risk factors. Methods: Over a 7-month period sexually active patients attending the young peoples’ clinic were offered C. trachomatis screening by nucleic acid amplification test. There was 100% acceptance rate among those offered the test. Patient demographics, reason for presentation at the clinic and reported symptoms were documented by the clinicians and correlated with laboratory findings. Results: 163 patients between the ages of 12–25 were tested, nine males and 154 females. The prevalence of chlamydia infection was 5.8% and was highest (16.0%) among patients presenting for the morning after pill. Inhibition of the nucleic acid amplification test occurred in 11.0% of urine samples. All patients with inhibited tests were asked to provide a repeat sample for retesting, but only 50% complied with this request. The majority of repeat samples (88.9%) had no inhibitors present and yielded a negative result. There was no correlation between symptoms and a positive chlamydia result. Conclusions: Chlamydia infection is common in young people engaging in unsafe sexual practice and cannot be predicted by the presence of symptoms. The high prevalence of infection in Geelong would make screening cost effective in this age group. Ongoing population screening of sexually active young people should be encouraged in community health centres. Inhibition of the nucleic acid amplification test was common but repeat testing of urine a few days later usually gave satisfactory results.


References


[1] Hocking J,  Fairley C. Need for screening for genital Chlamydia trachomatis infection in Australia. Aust N Z J Public Health 2003; 27(1): 80–1.
PubMed |

[2] Hollblad-Fadiman K,  Goldman SM. American College of Preventive Medicine Practice Policy Statement: screening for Chlamydia trachomatis.  Am J Prev Med 2003; 24(3): 287–92.
CrossRef | PubMed |

[3] Williams H,  Tabrizi SN,  Lee W,  Kovacs GT,  Garland S. Adolescence another risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia. Sex Transm Infect 2003; 79 31–4.
CrossRef | PubMed |

[4] Hocking J. Genital chlamydia — investigating the problem in Victoria. Vic Infect Dis Bull 2003; 6(1): 17.
CrossRef | PubMed |

[5] Watson E,  Templeton A,  Russell I,  Paavonen J,  Mardh P,  Stary A, et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002; 51 1021–1031.
CrossRef | PubMed |

[6] Counahan M,  Hocking J,  Fairley C. Enhanced chlamydia surveillance indicates more screening needed. MJA 2003; 178 523.
PubMed |

[7] Cates W,  Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991; 164 1771–81.
PubMed |

[8] Gleave T. Implementing a chlamydia pilot screening programme. Nursing Times 2002; 98(50).
PubMed |

[9] Burstein GR,  Murray PJ. Diagnosis and management of sexually transmitted disease pathogens among adolescents. Pediatr Rev 2003; 24(3): 75–82.
PubMed |

[10] Clutterbuck DJ. Managing genital Chlamydia trachomatis infection in Scotland: targeted opportunistic testing or a screening programme? Health Bull (Edinb) 2001; 59(6): 396–404.
PubMed |

[11] Cohen D,  Nsuami M,  Martin D,  Farley T. Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents. Pediatrics 1999; 104(6): 1281–5.
PubMed |

[12] Wiesenfeld HC,  Hillier SL,  Krohn MA,  Landers DV,  Sweet RL. Bacterial Vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. CID 2003; 36 663–8.
CrossRef |

[13] Honey E,  Augood C,  Templeton A,  Russell I,  Paavonen J,  Mardh P-A, et al. Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies.  Sex Transm Inf 2002; 78 406–12.
CrossRef |

[14] Garland SM,  Tabrizi S,  Hallo J,  Chen S. Assessment of Chlamydia trachomatis prevalence by PCR and LCR in women presenting for termination of pregnancy. Sex Transm Inf 2000; 76 173–6.
CrossRef |

[15] Mahoney J,  Chong S,  Jang D,  Luinstra K,  Faught M,  Dalby D, et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998; 36(11): 3122–6.
PubMed |

[16] Genc M,  Mardh P-A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Annal of Intern Med 1996; 124(1): 1–7.


[17] Underhill G,  Hewitt G,  McLean L,  Randall S,  Tobin J,  Harindra V. Who has chlamydia? The prevalence of genital tract Chlamydia trachomatis within Portsmouth and South East Hampshire, UK. J Fam Plann Reprod Health Care 2003; 29(1): 17–20.
PubMed |

[18] Miller PF,  Law M,  Torzillo PJ,  Kaldor J. Incident sexually transmitted infections and their risk factors in an Aboriginal community in Australia: a population based cohort study. Sex Trans Infect 2001; 77(1): 21–5.
CrossRef |

[19] McKay L,  Clery H,  Carrich-Anderson K,  Hollis S,  Scott G. Genital Chlamydia trachomatis infection in a subgroup of young men in the UK (Research letter). Lancet 2003; 361 1792.
CrossRef | PubMed |

[20] Smith R,  Miller K,  Storts DR. Performance optimization of Promega’s Taq DNA polymerase in PCR. Promega Notes 1996; 56 24.



Rent Article (via Deepdyve) Export Citation Cited By (6)